학술논문
Carfilzomib weekly 20/56 mg/m2 , lenalidomide and dexamethasone for early relapsed refractory multiple myeloma
Document Type
Letter
Author
Richez, V.; Legros, L.; Fuzibet, J.-G.; Gruchet, C.; Guidez, S.; Machet, A.; Moya, N.; Gardeney, H.; Franques, P.; Bobin, A.; Levy, A.; Sabirou, F.; Bouyier, S.; Leleu, X.; Fouquet, G.; Azais, I.; Durand, G.; Javaugue, V.; Bridoux, F.; Brigaud, A.; Plasse, F.; Bonnin, A.; Diolez, J.; Dieval, C.; Primault, S.; Barrier, J.; Fleck, E.; Daras, C.; Princet, I.; Bauwens, D.; Gil, A.; Avet-Loiseau, H.
Source
In: American Journal of Hematology . (American Journal of Hematology, January 2019, 94(1):E17-E20)
Subject
Language
English
ISSN
10968652
03618609
03618609